Page last updated: 2024-10-24

sphingosine-1-phosphate receptor activity

Definition

Target type: molecularfunction

Combining with the sphingolipid sphingosine-1-phosphate (S1P), and transmitting the signal across the membrane by activating an associated G-protein. [GOC:bf, PMID:12728273, Wikipedia:S1PR1]

Sphingosine-1-phosphate (S1P) receptors are G protein-coupled receptors (GPCRs) that play crucial roles in various cellular processes, including cell proliferation, survival, migration, and differentiation. These receptors bind to the bioactive lipid S1P, which acts as a potent signaling molecule. Upon S1P binding, the receptors activate downstream signaling pathways through heterotrimeric G proteins, leading to a cascade of intracellular events.

The molecular function of S1P receptor activity involves the following key steps:

1. **Ligand Binding:** S1P, produced by the phosphorylation of sphingosine, interacts with the extracellular domain of the S1P receptor. The binding is highly specific and involves interactions between S1P and amino acid residues within the receptor's binding site.

2. **Conformational Changes:** Ligand binding induces conformational changes within the receptor, particularly within the transmembrane domains. These structural rearrangements are essential for activating the receptor's intracellular signaling machinery.

3. **G Protein Activation:** The conformational changes in the receptor expose the intracellular loops, enabling the receptor to interact with and activate heterotrimeric G proteins. G proteins consist of three subunits: alpha, beta, and gamma. Upon activation, the alpha subunit dissociates from the beta and gamma subunits, carrying a GTP molecule.

4. **Downstream Signaling Cascades:** The activated G alpha subunit, loaded with GTP, interacts with various effector molecules, including phospholipase C (PLC), adenylyl cyclase (AC), and ion channels. These interactions initiate downstream signaling cascades, leading to the production of second messengers such as diacylglycerol (DAG), inositol trisphosphate (IP3), and cyclic AMP (cAMP).

5. **Cellular Responses:** The second messengers produced by the signaling cascades trigger a range of cellular responses, including changes in gene expression, cytoskeletal rearrangements, and enzyme activation. These responses ultimately contribute to the diverse physiological roles of S1P receptors, including immune cell trafficking, vascular development, and nervous system function.

In summary, the molecular function of S1P receptor activity involves a complex interplay between ligand binding, receptor conformational changes, G protein activation, downstream signaling cascades, and ultimately, cellular responses. These receptors play critical roles in various physiological processes, highlighting their importance in maintaining cellular homeostasis and regulating diverse biological functions.'
"

Proteins (8)

ProteinDefinitionTaxonomy
G-protein coupled receptor 6A G-protein coupled receptor 6 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P46095]Homo sapiens (human)
Sphingosine kinase 1A sphingosine kinase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NYA1]Homo sapiens (human)
Sphingosine kinase 2A sphingosine kinase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NRA0]Homo sapiens (human)
Sphingosine 1-phosphate receptor 5A sphingosine 1-phosphate receptor 5 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9H228]Homo sapiens (human)
Sphingosine 1-phosphate receptor 3A sphingosine 1-phosphate receptor 3 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q99500]Homo sapiens (human)
Sphingosine 1-phosphate receptor 1A sphingosine 1-phosphate receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P21453]Homo sapiens (human)
Sphingosine 1-phosphate receptor 4A sphingosine 1-phosphate receptor 4 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O95977]Homo sapiens (human)
Sphingosine 1-phosphate receptor 2A sphingosine 1-phosphate receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O95136]Homo sapiens (human)

Compounds (37)

CompoundDefinitionClassesRoles
fingolimod hydrochloridefingolimod hydrochloride : The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod).

Fingolimod Hydrochloride: A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.
hydrochlorideimmunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
fingolimodfingolimod : An aminodiol that consists of propane-1,3-diol having amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis. A prodrug, fingolimod is phosphorylated by sphingosine kinase to active metabolite fingolimod-phosphate, a structural analogue of sphingosine 1-phosphate.aminodiol;
primary amino compound
antineoplastic agent;
CB1 receptor antagonist;
immunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenolsubstituted aniline
1-[2-[2,5-dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-oxoethyl]pyrrolidine-2,5-dionearomatic ketone
(3-hydroxyphenyl)-[4-(phenylmethyl)-1-piperazinyl]methanethionearomatic amine
bml 241BML 241: inhibits increase of intracellular calcium ion concentration; conflicting evidence of whether it acts on sphingosine-1-phosphate receptorsL-alpha-amino acid
1-[4-(3-ethoxyphenoxy)butyl]imidazolearomatic ether
safingolsafingol: RN given refers to the (R-(R*,S*))-isomeramino alcohol
sew2871SEW2871: structure in first sourceoxadiazole;
ring assembly
5-[[(2-methylanilino)-sulfanylidenemethyl]amino]-1H-pyrazole-4-carboxylic acid methyl esterthioureas
3-[2-(2,4-dichlorophenoxy)ethoxy]-6-methyl-2-nitropyridinedichlorobenzene
sphingosine2-aminooctadec-4-ene-1,3-diol : A 2-aminooctadecene-1,3-diol having its double bond at position 4.

sphing-4-enine : A sphingenine in which the C=C double bond is located at the 4-position.

sphingenine : A 2-aminooctadecene-1,3-diol having (2S,3R)-configuration.

sphingoid : Sphinganine, its homologs and stereoisomers, and the hydroxy and unsaturated derivatives of these compounds.
sphing-4-eninehuman metabolite;
mouse metabolite
n,n-dimethylsphingenineN,N-dimethylsphingosine : A sphingoid that is sphingosine in which the two amino hydrogens are replaced by methyl groups.

N,N-dimethylsphingosine: a sphingosine kinase inhibitor
aminodiol;
sphingoid;
tertiary amino compound
EC 2.7.1.91 (sphingosine kinase) inhibitor;
metabolite
sphingosine 1-phosphatesphingosine 1-phosphate : A phosphosphingolipid that consists of sphingosine having a phospho group attached at position 1

sphingosine 1-phosphate: RN given refers to (R-(R*,S*-(E)))-isomer; RN for cpd without isomeric designation not available 8/89
sphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
N-cyclohexyl-5-propyl-3-isoxazolecarboxamidearomatic amide;
heteroarene
N,N-dicyclohexyl-5-propyl-3-isoxazolecarboxamidearomatic amide;
heteroarene
fty 720pfingolimod phosphate : A primary amino compound that is fingolimod in which one on the hydroxy groups has been converted into its dihydrogen phosphate derivative. It is the active metabolite of fingolimod.monoalkyl phosphate;
primary alcohol;
primary amino compound
antineoplastic agent;
immunosuppressive agent;
sphingosine-1-phosphate receptor agonist
es-2851-deoxysphinganine : A bioactive sphingoid, sphinganine, in which the terminal hydroxy group has been replaced by a hydrogen.

spisulosine: from marine organism, Spisula polynyma; structure in first source
amino alcohol;
sphingoid
antineoplastic agent
jte 013JTE 013: an Edg-5 antagonist

JTE-013 : A semicarbazide derivative that is semicarbazide in which the amino group at position 2 is replaced by a [1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]amino group and the amino group adjacent to the carbonyl is replaced by a (2,6-dichloropyridin-4-yl)amino group. It is a potent S1P2 antagonist (IC50 = 17.6 nM).
chloropyridine;
pyrazolopyridine
anti-asthmatic agent;
anti-inflammatory agent;
antineoplastic agent;
osteogenesis regulator;
pro-angiogenic agent;
sphingosine-1-phosphate receptor 2 antagonist
auy 954AUY 954: an S1P(1) receptor agonist; structure in first source
ponesimodponesimod: structure in first source
fty 720p
VPC 23019VPC 23019 : A secondary carboxamide resulting from the formal condensation of the carboxy group of O-phospho-D-serine with the amino group of m-octylaniline. An analogue of sphingosine-1-phosphate (S1P), it is a potent antagonist for both S1P1 and S1P3 receptors. It can inhibit S1P-induced migration of thyroid cancer cells, ovarian cancer cells, and neural stem cells.

VPC23019: inhibits S1P3 receptor; structure in first source
aromatic amide;
D-serine derivative;
organic phosphate;
phosphoric ester;
secondary carboxamide
sphingosine-1-phosphate receptor 1 antagonist;
sphingosine-1-phosphate receptor 3 antagonist
gw9508GW9508: structure in first sourcearomatic amine
cannabidivarincannabidivarin: from Cannabis sativamonoterpenoid
cs-2100
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amideorganochlorine compound
cym-5442oxadiazole;
ring assembly
siponimodsiponimod: S1P receptor modulator
5-(2,5-difluorophenyl)-N-(2,6-dimethylphenyl)-2-furancarboxamidearomatic amide;
furans
5-(2,5-dichlorophenyl)-N-(2,6-dimethoxyphenyl)-2-furancarboxamidearomatic amide;
furans
5-(2,5-dichlorophenyl)-N-[2,6-di(propan-2-yl)phenyl]-2-furancarboxamidearomatic amide;
furans
5-(2,5-dichlorophenyl)-N-(2,6-diethylphenyl)-2-furancarboxamidearomatic amide;
furans
N-(2,6-dimethylphenyl)-5-(4-methyl-3-thiophenyl)-2-furancarboxamidearomatic amide;
furans
bml 258
pf-543PF-543: Sphingosine Kinase 1 Selective Inhibitor; structure in first sourcesulfonamide
rome(2R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol : A 2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol that has R-configuration. It is a sphingosine kinase-2 inhibitor.

Rome: The capital city of Italy.
2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-olEC 2.7.1.91 (sphingosine kinase) inhibitor